Alkem Laboratories

Alkem Laboratories Enterprise Value

The Enterprise Value (EV) of Alkem Laboratories (ALKEM.NS) as of Nov 3, 2026 is 598.85 B INR. In the previous year, Enterprise Value (EV) was 615.54 B INR — a change of -2.71% (lower).

Enterprise Value

598.85 BINR

YoY

-2.71%

Last updated:

Enterprise Value (EV) of Alkem Laboratories is 2026 598.85 B INR. Enterprise Value (EV) of Alkem Laboratories was 2025 615.54 B INR. It decreases by -2.71% lower compared to the previous year.

The Alkem Laboratories Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2019
642.40 B INR
Jan 1, 2020
652.13 B INR
Jan 1, 2021
639.89 B INR
Jan 1, 2022
653.06 B INR
Jan 1, 2023
642.04 B INR
Jan 1, 2024
610.99 B INR
Jan 1, 2025
615.54 B INR
Jan 1, 2026
598.85 B INR
The Alkem Laboratories Enterprise Value history
YEAREnterprise ValueYoY
598.85 BINR-2.71%
615.54 BINR+0.74%
610.99 BINR-4.84%
642.04 BINR-1.69%
653.06 BINR+2.06%
639.89 BINR-1.88%
652.13 BINR+1.51%
642.40 BINR+0.34%
640.26 BINR+0.17%
639.17 BINR-0.37%
641.57 BINR-0.39%
644.05 BINR-0.45%
646.94 BINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Alkem Laboratories Stock analysis

What does Alkem Laboratories do? Alkem Laboratories Ltd is a leading Indian pharmaceutical company that was founded in 1973 and is headquartered in Mumbai. The company's main business model includes the development, manufacturing, and distribution of pharmaceutical formulations and active ingredients. Alkem Laboratories specializes in generics, branded drugs, and biosimilars, offering a comprehensive range of medical solutions. The company is divided into several divisions, including drug research and development, manufacturing, marketing, and sales. It focuses particularly on chronic diseases such as diabetes, cardiovascular diseases, cancer, neurological disorders, and infectious diseases. Alkem Laboratories employs over 20,000 employees worldwide and aims to improve the health and well-being of people globally. It offers a wide range of both prescription and over-the-counter products, including antibiotics, antifungals, cardiology, gastroenterology, urology, neurology, oncology, psychiatry, dermatology, and pediatrics. The company is committed to developing biosimilars that provide more affordable treatment options for serious diseases such as cancer and autoimmune diseases. It has developed an extensive portfolio of biosimilars, including Rituximab, Trastuzumab, and Adalimumab. Alkem Laboratories has also invested in research and development to create innovative solutions for the healthcare industry. It has established research centers in India, the USA, and Europe to discover new active ingredients, optimize processes, and develop innovative products. The company aims to lead in maintaining the highest quality standards and complying with strict regulatory requirements. Alkem Laboratories has certified facilities in India and the USA according to GMP guidelines. It also has a strong presence in the international pharmaceutical industry community and is a member of organizations such as the International Generic and Biosimilar Medicines Association, the Indian Pharmaceutical Alliance, and the US Pharmaceutical Research and Manufacturers of America. Overall, Alkem Laboratories is characterized by its extensive experience in the pharmaceutical industry and its commitment to the health and well-being of people worldwide. The company strives to create innovative solutions for the medical sector and aims to utilize its cutting-edge technology and expertise to meet the needs of patients globally. Alkem Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Alkem Laboratories stock

Enterprise Value (EV) of Alkem Laboratories is 598.85 B INR in 2026.

Enterprise Value (EV) of Alkem Laboratories changed from 615.54 B INR to 598.85 B INR, representing a -2.71% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Alkem Laboratories since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s INR, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' INR varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Alkem Laboratories with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Alkem Laboratories

All Key Metrics — Alkem Laboratories